Chiron Panacea Vaccines Private Limited, a dissolved private limited company, was established on 30 July 2004 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230MH2004PTC147790. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹9.00 Cr and a paid-up capital of ₹4.59 Cr.
Its leadership includes Masood Alam (Nominee Director), Kamal Dewandas Manik (Alternate Director), Devender Gupta (Additional Director). Past directors included Sonia Khalid, Masood Alam, Alexandre Philippe Sudarskis. Its latest AGM occurred on 24 May 2013, with the balance sheet filed on 31 March 2013. It is based at 7Th Floor, A Wing, Sagar Tech Plaza Sakinaka, Mumbai, Maharashtra, 400072.
U24230MH2004PTC147790
147790
30 July 2004
₹9.00 Cr
₹4.59 Cr
Roc Mumbai
Unlisted
Dissolved
Explore comprehensive insights into Chiron Panacea Vaccines Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Masood Alam | Nominee Director | 16 Dec 2010 | Current |
| Kamal Dewandas Manik | Alternate Director | 29 Jun 2013 | Current |
| Devender Gupta | Additional Director | 18 Jun 2012 | Current |
| Vinod Goel | Additional Director | 10 Dec 2010 | Current |
| Yau Yeung Joel Lau | Nominee Director | 07 Jul 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Alternate Director | 18 Jun 2012 | Past |
| Pramod Abcsdd | Additional Director | 14 Jun 2011 | Past |
| Pramod Abcsdd | Nominee Director | 16 Dec 2010 | Past |
| Pramod Abcsdd | Alternate Director | 10 Apr 2012 | Past |
| Pramod Abcsdd | Company Secretary | 01 Sep 2007 | Past |
| Pramod Abcsdd | Nominee Director | 30 Jul 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Chiron Panacea Vaccines's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Chiron Panacea Vaccines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Chiron Panacea Vaccines has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Chiron Panacea Vaccines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chiron Panacea Vaccines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kamal Dewandas Manik was appointed as a Alternate Director was appointed as a Alternate Director on 29 Jun 2013 & has been associated with this company since 12 years 5 months . was completed.
Progress on Chiron Panacea Vaccines Private Limited last Annual general meeting of members was held on 24 May 2013 as per latest MCA records. was documented.
Progress on Chiron Panacea Vaccines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Mumbai. was documented.
Progress on Devender Gupta was appointed as a Additional Director was appointed as a Additional Director on 18 Jun 2012 & has been associated with this company since 13 years 5 months . was documented.
Yau Yeung Joel Lau was appointed as a Nominee Director was appointed as a Nominee Director on 07 Jul 2011 & has been associated with this company since 14 years 4 months . was recorded as a recent event.
Progress on Masood Alam was appointed as a Nominee Director was appointed as a Nominee Director on 16 Dec 2010 & has been associated with this company since 14 years 11 months . was documented.
The CIN of Chiron Panacea Vaccines Private Limited is U24230MH2004PTC147790.
Chiron Panacea Vaccines Private Limited is headquartered at 7Th Floor, A Wing, Sagar Tech Plaza Sakinaka, Mumbai, Maharashtra, 400072.
Chiron Panacea Vaccines Private Limited was incorporated on 30 July 2004.
The current directors of Chiron Panacea Vaccines Private Limited are
The primary industry of Chiron Panacea Vaccines Private Limited is Chemicals.
Chiron Panacea Vaccines Private Limited is unlisted.
The authorized capital of Chiron Panacea Vaccines Private Limited is ₹9.00 Cr, and the paid-up capital is ₹4.59 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX